tirzepatide powder for compounding Ivím Health Preserving Muscle While Losing Fat:

The case report of autoimmune encephalitis after tirzepatide use, while isolated, raises the question of whether GLP-1/GIP receptor agonism can occasionally trigger aberrant immune responses rather than suppress them

Grifo agrees

The dual GIP/GLP-1 mechanism enhances insulin secretion, suppresses glucagon, slows gastric emptying, and reduces appetite via central nervous system signaling, producing greater glycemic and weight effects than selective GLP-1 receptor agonists [5]

Eli Lilly, the manufacturer of branded tirzepatide, has now released testing data showing significant impurities in compounded tirzepatide-B12 products, and the findings raise questions that every single person using these formulations needs to understand